cobenrich: Using Multiple Continuous Biomarkers for Patient Enrichment in
Two-Stage Clinical Designs
Enrichment strategies play a critical role in modern clinical trial design, especially as precision medicine advances the focus on patient-specific efficacy. Recent developments in enrichment design have introduced biomarker randomness and accounted for the correlation structure between treatment effect and biomarker, resulting in a two-stage threshold enrichment design. We propose novel two-stage enrichment designs capable of handling two or more continuous biomarkers.
    See Zhang, F. and Gou, J. (2025). Using multiple biomarkers for patient enrichment in two-stage clinical designs. Technical Report.
| Version: | 
1.0.1 | 
| Depends: | 
R (≥ 4.2.0) | 
| Imports: | 
tmvtnorm (≥ 1.2), stats (≥ 4.0.0) | 
| Published: | 
2025-04-15 | 
| DOI: | 
10.32614/CRAN.package.cobenrich | 
| Author: | 
Jiangtao Gou [aut, cre],
  Fengqing (Zoe) Zhang [aut] | 
| Maintainer: | 
Jiangtao Gou  <gouRpackage at gmail.com> | 
| License: | 
GPL-3 | 
| NeedsCompilation: | 
no | 
| CRAN checks: | 
cobenrich results | 
Documentation:
Downloads:
Linking:
Please use the canonical form
https://CRAN.R-project.org/package=cobenrich
to link to this page.